NCT05168449Completed
The Impact of Pharmacist-led Mobile Application on Adherence in Chronic Kidney Disease Patients
The Impact of Pharmacist - Led Mobile Application on Medication Adherence and Efficacy in Chronic Kidney Disease Patients
Source: ClinicalTrials.gov · Last updated 9 Feb 2024
Brief summary (registry, in English)
The aim of the study is to assess the impact of pharmacist led mobile application on adherence and efficacy of medication in chronic kidney disease patients
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 86 (actual)
- First submitted
- 24 Nov 2021
- Start date
- 17 Sept 2022
- Primary completion date
- 5 Dec 2023
- Lead sponsor
- Cairo University
- Diseases
- Chronic kidney disease
- NCT number
- NCT05168449
What you commit to
- Study type: Interventional
- Participants enrolled: 86
- From 17 Sept 2022 to the primary completion date, 5 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- On dialysis due to loss of kidney function
- Pregnancy due to altered physiology
Who the study is looking for
- Stages 2-5 of chronic kidney disease
- Literate
- Ownership of android smart phone compatible with the application
- Poly-pharmacy
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Private Clinic Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.